Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Quest LaboratoriesNSE:QUESTLAB +8.08%44 3-Year Book Growth Rate is 85.70% as of Mar. 2026, which is at its 10-year median of 85.70. GuruFocus rates NSE:QUESTLAB with a GF Score™ of 44/100. The stock has 5 warning signs investors should review. Among 914 Drug Manufacturers companies, Quest Laboratories ranks better than 97.7% on this metric.
During the past 12 months, Quest Laboratories's average Book Value per Share Growth Rate was 18.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 85.70% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 81.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 6 years, the highest 3-Year average Book Value per Share Growth Rate of Quest Laboratories was 101.50% per year. The lowest was 69.50% per year. And the median was 85.70% per year.
Quest Laboratories (NSE:QUESTLAB) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Quest Laboratories 3-Year Book Growth Rate Related Terms
NSE:QUESTLAB vs LLY, JNJ, ABBV: 3-Year Book Growth Rate Comparison
For the Drug Manufacturers - General subindustry, Quest Laboratories's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quest Laboratories 3-Year Book Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Quest Laboratories's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Quest Laboratories's 3-Year Book Growth Rate falls into.
Quest Laboratories 3-Year Book Growth Rate Calculation
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 85.70% mean?
Quest Laboratories (NSE:QUESTLAB) has a 3-Year Book Growth Rate of 85.70% as of Mar. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Quest Laboratories and its competitors. This is near median its historical median of 85.70. Over the past decade, Quest Laboratories' 3-Year Book Growth Rate has ranged from 69.50 to 101.50. According to the industry distribution chart, Quest Laboratories ranks #21 out of 914 companies in the Drug Manufacturers industry, placing it in the top 2.3%.
Is Quest Laboratories' 3-Year Book Growth Rate too high?
Quest Laboratories' current 3-Year Book Growth Rate of 85.70% is near median its 10-year median of 85.70. Over the past 10 years, this metric has ranged from a low of 69.50 to a high of 101.50. The Drug Manufacturers industry median 3-Year Book Growth Rate is 4.75. Quest Laboratories' value of 85.70% is 1704.2% above this industry median. Based on the distribution chart, Quest Laboratories ranks #21 out of 914 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Quest Laboratories has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Quest Laboratories' 3-Year Book Growth Rate compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Quest Laboratories ranks #21 out of 914 companies for 3-Year Book Growth Rate. This places Quest Laboratories in the top 2% of its industry — outperforming the majority of peers. The industry median 3-Year Book Growth Rate is 4.75. Quest Laboratories' value of 85.70% is 1704.2% above this benchmark. Historically, Quest Laboratories' own 3-Year Book Growth Rate has ranged from 69.50 to 101.50 over the past decade. While the company's 10-year median is 85.70 vs. the industry median of 4.75, Quest Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Drug Manufacturers company?
The median 3-Year Book Growth Rate among Drug Manufacturers companies is 4.75, based on 914 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Quest Laboratories's current 3-Year Book Growth Rate of 85.70% is 1704.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Quest Laboratories and its competitors. For the Drug Manufacturers industry, the median 3-Year Book Growth Rate is 4.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Quest Laboratories's current 3-Year Book Growth Rate is 85.70%, which is near median its own 10-year median of 85.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quest Laboratories stock overvalued right now?
Quest Laboratories (NSE:QUESTLAB) has a current 3-Year Book Growth Rate of 85.70%. The current 3-Year Book Growth Rate is 85.70%, which is near median its 10-year median of 85.70 and 1704.2% above the Drug Manufacturers industry median of 4.75. Quest Laboratories' overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Quest Laboratories (NSE:QUESTLAB), the current 3-Year Book Growth Rate is 85.70% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids, among others. The company operates in a single segment of Drugs and Chemicals.
44GF Score
Get the complete analysis for NSE:QUESTLAB
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:QUESTLAB has been successfully added to your 
